葡萄糖-胰岛素-钾对肿瘤细胞减灭术联合腹腔热灌注化疗患者手术结束时乳酸水平的影响:随机对照试验研究方案
本研究为单中心、随机、单盲结局评估临床试验,计划纳入80例18至64岁接受肿瘤细胞减灭术联合腹腔热灌注化疗的腹膜癌患者,按1:1随机分配至改良葡萄糖-胰岛素-钾组或常规管理组,主要结局为手术结束时血浆乳酸水平,旨在评估改良葡萄糖-胰岛素-钾降低手术结束时乳酸水平及减少术后早期并发症的获益。
要点
- 肿瘤细胞减灭术联合腹腔热灌注化疗与高乳酸水平相关,术后早期并发症发生率随乳酸升高而增加。
- 改良葡萄糖-胰岛素-钾 versus 常规管理,主要结局为手术结束时血浆乳酸水平。
- 次要结局包括术中乳酸和血糖最高水平及波动范围、拔管时间、术后24小时APACHE-II评分等。
核心结论
- 研究旨在评估改良葡萄糖-胰岛素-钾在肿瘤细胞减灭术联合腹腔热灌注化疗中降低手术结束时乳酸水平并进一步减少术后早期并发症发生率的优势。
研究设计与样本
- 单中心、随机、单盲结局评估临床试验,计划纳入80例18至64岁接受肿瘤细胞减灭术联合腹腔热灌注化疗的腹膜癌患者,按1:1随机分配至改良葡萄糖-胰岛素-钾组或常规治疗组。
关键数值与推荐
- 主要结局为手术结束时血浆乳酸水平。
- 次要结局包括术中乳酸和血糖的最高水平及波动范围、拔管时间、术后24小时APACHE-II评分、术后排便和排气时间、术后乳酸清除时间、术后肝肾功能、术后7天内并发症发生率、重症监护室住院时间(LIS)、住院时间(LHS)和总住院费用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been established as an effective treatment for peritoneal cancer (PC). However, this kind of combination therapy is associated with a high lactate level. Moreover, studies have suggested that the rate of complications early after surgery directly increased with elevated lactate levels. Glucose-insulin-potassium (GIP), a potent cardioprotective intervention, has been demonstrated to adjust blood glucose (BG) levels and reduce lactate levels. However, the insulin-glucose ratio should be adjusted according to the surgery performed. Here, we aimed to evaluate the advantages of using modified GIP during CRS/HIPEC to reduce the lactate level at the end of surgery and further reduce the incidence of early postoperative complications. METHODS AND ANALYSIS: The modified GIP versus conventional management during surgery study is a single-center, randomized, single-blinded outcome assessment clinical trial of 80 patients with PC who are between 18 and 64 years old and undergoing CRS/HIPEC. Participants will be randomly allocated to receive modified GIP or conventional treatment (1:1). The primary outcome will be the plasma lactate level at the end of surgery. The secondary outcomes will include the highest levels and fluctuation ranges of lactate and BG during surgery, extubation time, APACHE-II score 24 h after surgery, postoperative defecation and exhaust time, postoperative lactate clearance time, postoperative liver and kidney function, incidence of complications within 7 days after surgery, length of intensive care unit stay (LIS), length of hospital stay (LHS), and total cost of hospitalization. ETHICS AND DISSEMINATION: The trial protocol was approved by the Scientific Research Ethics Committee of Beijing Shijitan Hospital Affiliated with Capital Medical University, approval number sjtky11-1x-2022(118). The results will be published in international peer-reviewed journals. TRIAL REGISTRATION: ChiCTR2200057258. Registered on March 5, 2022.
引用
- Hu Y, Gao T, Wang X, et al. Effect of glucose-insulin-potassium on lactate levels at the end of surgery in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a randomized controlled trial. Trials. 2024. PMID: 39438970. doi:10.1186/s13063-024-08161-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。